Mixed Topics
From the Journals
Industry Payments to Peer Reviewers Scrutinized at Four Major Medical Journals
Major medical journals relied on peer reviewers who received more than $64 million in non-research payments between 2020 and 2022.
From the Journals
Ancient Viruses in Our DNA Hold Clues to Cancer Treatment
Targeting remnants of a virus in our DNA could lead to more effective cancer treatment with fewer side effects.
Latest News
Study Detects Bacteria in Tattoo, Permanent Makeup Inks
Of the 75 ink samples tested, 26 were contaminated with 34 bacterial isolates classified into 14 genera and 22 species.
Feature
Doctors Endorsing Products on X May Not Disclose Company Ties
Researchers review posts by physicians on X, looking for key words that might indicate that the posts were intended as endorsements of a product...
Feature
Follow-Up Outcomes Data Often Missing for FDA Drug Approvals Based on Surrogate Markers
As the FDA’s use of surrogate endpoints in the drug approval process is increasing, researchers are concerned important postapproval or validation...
Feature
Chatbots Seem More Empathetic Than Docs in Cancer Discussions
AI gives readable, high quality, and empathetic responses to social media queries about cancer.
Conference Coverage
New mRNA Vaccines in Development for Cancer and Infections
Different forms and designations of mRNA vaccines are used, depending on the application and desired effect.
Latest News
Oral Herpes Tied to Double Dementia Risk in Older Adults
Past infection with HSV in older adults was linked to higher risk for developing dementia, study finds.
Latest News
Is Metformin a ‘Drug for All Diseases’?
Long time diabetes medication, metformin may have utility in treatment of obesity, liver disease, cancers, and other diseases.
Latest News
The Ghost Research Haunting Nordic Medical Trials
Numerous studies could be considered ‘medical research waste’ or research that was never shared publicly, study finds.
Latest News
New Antibiotic Promising for Complicated UTIs
Study suggests cefepime-taniborbactam could be useful in treating complex UTIs.